COMMISSIONG GERALD 4
4 · AMARANTUS BIOSCIENCE, INC. · Filed Feb 21, 2013
Insider Transaction Report
Form 4
COMMISSIONG GERALD
DirectorCEO10% Owner
Transactions
- Purchase
Common Stock
2013-01-11$0.07/sh+10,000$742→ 7,502,300 total - Purchase
Common Stock
2013-01-11$0.07/sh+15,000$1,115→ 7,517,300 total - Purchase
Common Stock
2013-01-11$0.07/sh+15,000$1,115→ 7,517,300 total - Purchase
Common Stock
2013-01-14$0.09/sh+15,000$1,365→ 7,542,300 total - Purchase
Common Stock
2013-02-05$0.08/sh+47,900$4,019→ 7,590,200 total - Purchase
Common Stock
2013-02-05$0.08/sh+2,100$176→ 7,592,300 total - Purchase
Common Stock
2013-02-21$0.07/sh+50,000$3,625→ 7,642,300 total - Award
Common Stock Options
2011-05-04$0.03/sh+269,329$7,272→ 269,329 totalExercise: $0.03→ CommonStock (269,329 underlying) - Award
5% Convertible Preferred Stock
2012-07-15+471,250→ 23,531,829 totalExercise: $1.50→ Common Stock (23,562,500 underlying) - Award
5% Convertible Preferred Stock
2012-11-04+500,000→ 48,531,829 totalExercise: $1.50→ CommonStock (25,000,000 underlying)
Footnotes (3)
- [F1]No specific date set.
- [F2]Set based upon current price, actual price will be determined on the date of conversion.
- [F3]N/A